MTOR and cardiac hypertrophy: Inhibition of AKT/mTOR signaling also attenuates or reverses pressure overload-associated cardiac hypertrophy [19,22,23], supporting our findings that there is a potential regulatory role for AKT/mTOR in pathological HCM in NSML [11,12].